2.200
+4,76%
2026-10-19
Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +23.4% | -31.4% | 2 / 3 | +100.8% | -4.77 pp | +4.68 pp | -14.9% | 0.28 | — | 252 | +100,8% | −7,3 | +23,4% | — | -1.63 | — |
| Pts | 4 | 0 | 8 | 12 | 0 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 2.200 (close price on 2026-10-19)EPS (TTM): −1.015,7
Financial charts
1.Revenue & growth
VND bn252Q2/26
1.Revenue & growth
VND bn252Q2/26
2.Profit & growth
VND bn-7,28Q2/26
3.Profit mix (Penman)
VND bn-42,2Q2/26
4.Margins & cost structure
%5.0%Q2/26
5.Returns & cash cycle
% · days-0.3%Q2/26
6.Earnings quality & cash
VND bn7,30Q2/26
7.Asset structure
VND bn534Q2/26
8.Funding & debt health
VND bn · times534Q2/26
9.Revenue backlog
VND bn16,4Q2/26
10.Valuation
times · %-2,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-175Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26